Physician profile
Maxime Cannesson
NPI 1114150810
$336,074.22
in general payments reported to CMS, 2019-2025
6 companies · $21K in 2025
The $21K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90K · 2020: $49K · 2021: $84K · 2022: $25K · 2023: $31K · 2024: $36K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Royalty Or License: $23K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $13K · Education: $8,268 · Food and Beverage: $1,808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,000.00 |
| Royalty Or License | $23,010.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,073.36 |
| Travel and Lodging | $13,472.47 |
| Education | $8,268.03 |
| Food and Beverage | $1,808.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $242,964.55 | 2019-2024 | Hemosphere |
| Stryker Corporation | $68,567.23 | 2021 | |
| Becton, Dickinson and Company | $23,379.41 | 2024-2025 | Hemosphere |
| Masimo Corporation | $1,000.00 | 2025 | Patient Safetynet System, Set and Rainbow Set |
| Medtronic, INC. | $135.47 | 2023-2024 | Invos, Nellcor |
| Hill-Rom Company, INC | $27.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxime Cannesson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.